Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 HER2-positive Breast Cancer 6 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Rare Tumor 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 HER2-expressing Advanced Solid Tumors 1 HER2 Positive Breast Cancer 1 HER2 Insertion Mutation Positive Advanced NSCLC 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasm Female 1 Breast Cancer Metastatic 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Advanced Breast Cancer 1

Interventions

pyrotinib 1 anlotinib 1 Radiosurgery 1 Paclitaxel 1 Fulvestrant 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Neoplasm Female × pyrotinib × Clear all

NCT06234137 2024-01-31

neoPICD

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡